$98.35
0.70%
NYSE, Oct 05, 04:06 pm EDT. Closed.
ISIN
US4333131039
Symbol
HNGE

Hinge Health Target price 2026 - Analyst rating & recommendation

Hinge Health Classifications & Recommendation

Buy
91%
Hold
9%

Hinge Health Price Target

Target Price $107.10
Price $98.35
Potential
Number of Estimates 17
17 Analysts have issued a price target Hinge Health 2027 . The average Hinge Health target price is $107.10. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 22 analysts: 20 Analysts recommend Hinge Health to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Hinge Health stock has an average upside potential 2027 of . Most analysts recommend the Hinge Health stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 587.86 876.34
50.58% 49.07%
EBITDA Margin -92.07% 29.60%
1,845.02% 132.15%
Net Margin -72.14% 22.42%
2,260.77% 131.08%

19 Analysts have issued a sales forecast Hinge Health 2026 . The average Hinge Health sales estimate is

$876m
unlock
. This is
21.70% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$916m 27.23%
unlock
, the lowest is
$839m 16.53%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $588m 50.58%
2026
$876m 49.07%
unlock
2027
$1.1b 26.43%
unlock
2028
$1.4b 23.74%
unlock
2029
$1.6b 19.26%
unlock
2030
$2.0b 20.18%
unlock
2031
$2.3b 19.03%
unlock

14 Analysts have issued an Hinge Health EBITDA forecast 2026. The average Hinge Health EBITDA estimate is

$259m
unlock
. This is
163.64% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$344m 249.29%
unlock
, the lowest is
$235m 139.05%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-541m 2,828.79%
2026
$259m 147.93%
unlock
2027
$338m 30.33%
unlock
2028
$469m 38.60%
unlock
2029
$528m 12.76%
unlock
2030
$660m 24.96%
unlock
2031
$819m 24.04%
unlock

EBITDA Margin

2025 -92.07% 1,845.02%
2026
29.60% 132.15%
unlock
2027
30.51% 3.07%
unlock
2028
34.18% 12.03%
unlock
2029
32.32% 5.44%
unlock
2030
33.60% 3.96%
unlock
2031
35.01% 4.20%
unlock

19 Hinge Health Analysts have issued a net profit forecast 2026. The average Hinge Health net profit estimate is

$196m
unlock
. This is
82.98% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$285m 165.90%
unlock
, the lowest is
$176m 63.99%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-424m 3,454.82%
2026
$196m 146.32%
unlock
2027
$250m 27.31%
unlock
2028
$364m 45.44%
unlock
2029
$450m 23.69%
unlock
2030
$545m 21.09%
unlock
2031
$655m 20.27%
unlock

Net Margin

2025 -72.14% 2,260.77%
2026
22.42% 131.08%
unlock
2027
22.57% 0.67%
unlock
2028
26.53% 17.55%
unlock
2029
27.52% 3.73%
unlock
2030
27.73% 0.76%
unlock
2031
28.01% 1.01%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -7.77 2.45
5,080.00% 131.53%
P/E 39.87
EV/Sales 8.55

19 Analysts have issued a Hinge Health forecast for earnings per share. The average Hinge Health EPS is

$2.45
unlock
. This is
91.41% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$3.56 178.13%
unlock
, the lowest is
$2.20 71.88%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-7.77 5,080.00%
2026
$2.45 131.53%
unlock
2027
$3.12 27.35%
unlock
2028
$4.54 45.51%
unlock
2029
$5.61 23.57%
unlock
2030
$6.79 21.03%
unlock
2031
$8.17 20.32%
unlock

P/E ratio

Current 76.30 2,517.00%
2026
39.87 47.75%
unlock
2027
31.32 21.44%
unlock
2028
21.53 31.26%
unlock
2029
17.41 19.14%
unlock
2030
14.38 17.40%
unlock
2031
11.95 16.90%
unlock

Based on analysts' sales estimates for 2026, the Hinge Health stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 10.40 100.39%
2026
8.55 17.80%
unlock
2027
6.76 20.91%
unlock
2028
5.46 19.18%
unlock
2029
4.58 16.15%
unlock
2030
3.81 16.80%
unlock
2031
3.20 15.99%
unlock

P/S ratio

Current 10.95 88.14%
2026
8.99 17.83%
unlock
2027
7.11 20.91%
unlock
2028
5.75 19.18%
unlock
2029
4.82 16.15%
unlock
2030
4.01 16.79%
unlock
2031
3.37 15.99%
unlock

Current Hinge Health Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Needham
Locked
➜
Locked
Locked Sep 30 2026
Baird
Locked
➜
Locked
Locked Sep 22 2026
Stifel
Locked
➜
Locked
Locked Sep 08 2026
Truist Securities
Locked
➜
Locked
Locked Aug 11 2026
Needham
Locked
➜
Locked
Locked Aug 05 2026
Barclays
Locked
➜
Locked
Locked Aug 05 2026
RBC Capital
Locked
➜
Locked
Locked Aug 05 2026
Analyst Rating Date
Locked
Needham:
Locked
➜
Locked
Sep 30 2026
Locked
Baird:
Locked
➜
Locked
Sep 22 2026
Locked
Stifel:
Locked
➜
Locked
Sep 08 2026
Locked
Truist Securities:
Locked
➜
Locked
Aug 11 2026
Locked
Needham:
Locked
➜
Locked
Aug 05 2026
Locked
Barclays:
Locked
➜
Locked
Aug 05 2026
Locked
RBC Capital:
Locked
➜
Locked
Aug 05 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today